for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Varian Medical Systems, Inc.

var

Latest Trade

138.55USD

Change

0.04(+0.03%)

Volume

210,199

Today's Range

137.61

 - 

139.50

52 Week Range

103.92

 - 

142.50

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
138.51
Open
138.42
Volume
210,199
3M AVG Volume
14.72
Today's High
139.50
Today's Low
137.61
52 Week High
142.50
52 Week Low
103.92
Shares Out (MIL)
90.90
Market Cap (MIL)
12,590.22
Forward P/E
25.87
Dividend (Yield %)
--

Latest Developments

More

Varian Medical Systems Inc Announces Updates To Previously Reported GAAP Preliminary Financial Results For Its Q4 & Full Fiscal Year 2019

Varian Medical Systems Reports Q4 Non-GAAP Earnings Per Share Of $1.21

Varian Expects To Benefit From Linear Accelerator Tariff Exclusion In China

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Varian Medical Systems, Inc.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.

Industry

Medical Equipment & Supplies

Contact Info

3100 Hansen Way Bldg 4A

+1.650.4934000

https://www.varian.com/

Executive Leadership

R. Andrew Eckert

Independent Chairman of the Board

Dow R. Wilson

President, Chief Executive Officer, Director

Timothy E. Guertin

Independent Vice Chairman of the board

J. Michael Bruff

Chief Financial Officer, Senior Vice President - Finance

Gary E. Bischoping

President - Interventional Oncology Solutions

Key Stats

2.00 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

2.7K

2018

2.9K

2019

3.2K

2020(E)

3.5K
EPS (USD)

2017

3.600

2018

4.420

2019

4.630

2020(E)

5.355
Price To Earnings (TTM)
42.71
Price To Sales (TTM)
3.90
Price To Book (MRQ)
7.11
Price To Cash Flow (TTM)
32.17
Total Debt To Equity (MRQ)
23.19
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
14.50
Return on Equity (TTM)
8.11

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up